WVE-006, the leading GalNAc-RNA editing oligonucleotide designed to correct AAT protein and address both lung and liver ...

Congress can modernize our healthcare system by passing the SOAR Act and enabling beneficiaries to live on their terms with the help of supplemental oxygen.

Ascendis’ likely approval of TransCon CNP for achondroplasia poses a major threat to BioMarin’s best-selling drug. Read why I'm downgrading BMRN stock to Hold.

Two months after laying off 20% of its staff, Korro Bio says it has not retreated from its “3-2-1” corporate strategy as it prepares to release interim clinical data on its lead candidate KRRO-110 in ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent ...

Tiny fat bubbles carrying gene therapy have successfully repaired DNA in the lungs and liver of animals with alpha-1 ...

Alpha-1 antitrypsin deficiency (AATD), bronchoscopic lung volume reduction (BLVR), COPD, emphysema, endobronchial valves, hyperinflation, interventional pulmonology, lung volume reduction therapy.

Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s how that could affect patients ...

Patients with anti–PD-1–resistant melanoma (MEL) have no well-defined standard of care. BO-112 is a synthetic, double-stranded RNA (poly I:C) nanoplexed with polyethylenimine that when administered ...

Generation Alpha’s internet lingo is mutating faster than teachers, parents and AI models can keep up – potentially exposing youngsters to bullying and grooming that trusted adults and AI ...

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed.